Key Points
- Insider sales: CEO Virgilio Deloy Capobian Gibbon sold 800 shares on March 26 at $15.21 and 3,900 shares on March 25 at $15.18, generating about $71,370 in proceeds and leaving him with 153,748 shares valued at roughly $2.34 million.
- Dividend announced: Afya declared an annual dividend of $0.656 per share payable April 6 (record date March 25), a figure the report states implies a yield of 433.0% and a payout ratio of 45.21%.
- Recent results and outlook: Afya beat EPS expectations ($0.41 vs. $0.36) but missed revenue estimates, and analysts hold a consensus "Hold" rating with a $17.30 price target.
Afya Limited (NASDAQ:AFYA - Get Free Report) CEO Virgilio Deloy Capobian Gibbon sold 800 shares of the stock in a transaction on Thursday, March 26th. The stock was sold at an average price of $15.21, for a total transaction of $12,168.00. Following the sale, the chief executive officer directly owned 153,748 shares in the company, valued at $2,338,507.08. This trade represents a 0.52% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink.
Virgilio Deloy Capobian Gibbon also recently made the following trade(s):
- On Wednesday, March 25th, Virgilio Deloy Capobian Gibbon sold 3,900 shares of Afya stock. The shares were sold at an average price of $15.18, for a total transaction of $59,202.00.
Afya Price Performance
Shares of NASDAQ:AFYA opened at $14.75 on Friday. The company has a market cap of $1.38 billion, a PE ratio of 10.10, a P/E/G ratio of 0.66 and a beta of 0.52. Afya Limited has a fifty-two week low of $13.00 and a fifty-two week high of $19.90. The firm has a 50-day simple moving average of $14.39 and a 200 day simple moving average of $14.74. The company has a quick ratio of 0.98, a current ratio of 2.20 and a debt-to-equity ratio of 0.21.
Afya (NASDAQ:AFYA - Get Free Report) last issued its earnings results on Wednesday, March 11th. The company reported $0.41 EPS for the quarter, beating analysts' consensus estimates of $0.36 by $0.05. The company had revenue of $147.08 million during the quarter, compared to the consensus estimate of $174.74 million. Afya had a return on equity of 18.77% and a net margin of 20.31%. On average, sell-side analysts anticipate that Afya Limited will post 1.52 EPS for the current year.
Afya Dividend Announcement
The business also recently disclosed an annual dividend, which will be paid on Monday, April 6th. Investors of record on Wednesday, March 25th will be paid a dividend of $0.656 per share. This represents a yield of 433.0%. The ex-dividend date is Wednesday, March 25th. Afya's dividend payout ratio is presently 45.21%.
Wall Street Analyst Weigh In
AFYA has been the subject of several recent research reports. Zacks Research upgraded shares of Afya from a "strong sell" rating to a "hold" rating in a research report on Monday, March 9th. UBS Group restated a "neutral" rating and issued a $16.00 target price (down from $18.00) on shares of Afya in a research report on Friday, January 16th. Wall Street Zen upgraded shares of Afya from a "buy" rating to a "strong-buy" rating in a research note on Saturday, March 14th. JPMorgan Chase & Co. reiterated a "neutral" rating and set a $22.00 price objective (down from $24.50) on shares of Afya in a research report on Wednesday, January 7th. Finally, Bank of America lowered Afya from a "buy" rating to a "neutral" rating and decreased their price objective for the stock from $22.00 to $17.00 in a report on Tuesday, February 24th. One research analyst has rated the stock with a Buy rating and seven have issued a Hold rating to the stock. Based on data from MarketBeat, Afya has a consensus rating of "Hold" and a consensus price target of $17.30.
View Our Latest Research Report on AFYA
Institutional Investors Weigh In On Afya
Several institutional investors have recently bought and sold shares of AFYA. Goldman Sachs Group Inc. lifted its holdings in Afya by 167.3% in the first quarter. Goldman Sachs Group Inc. now owns 45,093 shares of the company's stock worth $809,000 after purchasing an additional 28,226 shares during the period. Geode Capital Management LLC raised its position in shares of Afya by 85.1% during the 2nd quarter. Geode Capital Management LLC now owns 52,111 shares of the company's stock worth $931,000 after buying an additional 23,961 shares in the last quarter. Quadrature Capital Ltd bought a new stake in shares of Afya during the 2nd quarter worth about $181,000. Quantbot Technologies LP acquired a new stake in shares of Afya in the 2nd quarter worth approximately $117,000. Finally, Arrowstreet Capital Limited Partnership boosted its holdings in shares of Afya by 5.6% in the second quarter. Arrowstreet Capital Limited Partnership now owns 68,169 shares of the company's stock valued at $1,217,000 after acquiring an additional 3,626 shares in the last quarter. Institutional investors and hedge funds own 88.02% of the company's stock.
About Afya
(
Get Free Report)
Afya Ltd. operates as a leading provider of medical education and training services in Brazil. The company offers a comprehensive suite of educational programs that span undergraduate medical degrees, residency exam preparation, continuing medical education (CME) and digital learning platforms. Through a network of partner institutions and its own campus operations, Afya supports students at every stage of the medical training continuum, from enrollment in medical schools to ongoing professional development for practicing physicians.
At the core of Afya's offerings is its undergraduate medical program, delivered through a combination of in-person courses at affiliated campuses and fully digital curricula.
See Also
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
